Temporal trends in primary payers in pediatric heart transplant and association with long-term survival

Kathryn Restaino1, Xuemei Zhang2, Jennifer A Faerber2

  • 1Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Pediatric Transplantation
|February 8, 2023
PubMed

Insights

Public insurance is increasingly common for pediatric heart transplants (HT), but it is linked to worse long-term outcomes. This trend highlights disparities in pediatric HT, necessitating efforts to ensure equitable results for all children undergoing this procedure.

Area of Science:

  • Pediatric Cardiology
  • Transplantation Medicine
  • Health Services Research

Background:

  • Pediatric heart transplantation (HT) is a complex and resource-intensive procedure.
  • In adults, a rise in public insurance for HT correlates with poorer outcomes compared to private insurance.
  • Data on funding trends and outcomes for pediatric HT are lacking.

Purpose of the Study:

  • To describe trends in insurance coverage for pediatric heart transplantation.
  • To evaluate the association between insurance type and post-transplant outcomes in children.

Main Methods:

  • Utilized the United Network for Organ Sharing (UNOS) database for pediatric patients (<18 years) from 2004-2021.
  • Analyzed primary payer at listing, transplant, and 1-5 years post-transplant.
  • Employed generalized logit models for trend analysis and multivariable Cox regression for outcome analysis.

Main Results:

  • Over 6382 pediatric patients were included, with a growing proportion having public insurance at the time of HT.
  • Public insurance at HT was associated with a significantly increased risk of death or re-transplant beyond 2 months post-transplant (e.g., adjusted HR of 1.43 at 6 months).

Conclusions:

  • A significant trend towards increased public insurance coverage in pediatric HT recipients exists.
  • Worse long-term outcomes are observed in Black patients and those with public insurance at the time of HT.
  • These findings underscore disparities in pediatric HT and the critical need for equitable outcomes.
Abstract